No specific dose of D-mannose has been shown to cause kidney damage in humans. Despite widespread online concern, clinical trials using the supplement for urinary tract infection prevention have not reported kidney injury as a side effect, and no human study has identified a threshold at which D-mannose becomes nephrotoxic. The worry traces mainly to laboratory research on embryonic kidney tissue and to metabolomic studies linking elevated blood mannose levels with chronic kidney disease, neither of which translates neatly into a dosing limit for someone taking a supplement. The gap between what the lab data suggest and what human evidence actually shows is worth understanding in detail.
Typical Supplement Doses and How They Were Tested
Most D-mannose supplements marketed for UTI prevention deliver somewhere between 500 mg and 2 g per day. The two most widely cited clinical trials both used 2 g of D-mannose powder daily. A 2013 randomized trial gave 103 women 2 g dissolved in water every day for six months as UTI prophylaxis.1PubMed. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial A 2024 trial published in JAMA Internal Medicine used the same 2 g daily dose in a similar prevention design.2JAMA Internal Medicine. d-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial Neither trial flagged kidney-related adverse events. A separate human study administered roughly 0.1 g per kilogram of body weight twice daily for a week and found no negative effects on glucose tolerance, inflammation markers, or insulin levels.3PubMed. Metabolism For a 70 kg person, that comes to about 7 g twice daily, well above what any UTI supplement recommends. Even at that higher intake, no signs of kidney harm appeared.
These trials were relatively short, ranging from one week to six months, and none enrolled people with pre-existing kidney disease. So while the doses tested appear safe in healthy adults and in adults with recurrent UTIs, the data do not tell us much about what happens at very high doses taken over years, or in people whose kidneys are already compromised.
How Your Kidneys Process D-Mannose
D-mannose is a simple sugar that your body already produces in small amounts and uses for glycoprotein synthesis. When you swallow a supplement, most of the mannose is absorbed in the gut and enters the bloodstream. From there, the kidneys filter it out, and a good portion ends up in your urine, which is exactly why it is thought to help with UTIs: mannose in the urine can bind to certain bacteria and stop them from sticking to the bladder wall.
The kidneys are not passive in this process. They have a dedicated transport system for reclaiming mannose from the fluid being filtered. Research on kidney brush-border membranes identified a sodium-dependent mannose transporter with high affinity and limited capacity.4PubMed. A D-mannose transport system in renal brush-border membranes A later study in rat kidney tissue confirmed these characteristics and found the system had low capacity but very high affinity, meaning it grabs mannose efficiently but can only handle a modest amount at a time.5PubMed. Expression and molecular characterization of rat renal D-mannose transport in Xenopus oocytes More recently, the transporter SGLT-5, found specifically in the human kidney, was characterized as a kidney mannose transporter with high capacity for mannose and fructose.6PubMed. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter
The practical implication is that when you take a supplement dose, your kidneys reabsorb some of the mannose and let the rest pass into the urine. If the amount overwhelms the transporter’s capacity, more mannose simply stays in the urine rather than building up in kidney cells. That overflow mechanism is actually the point for UTI prevention. But the question of whether consistently saturating these transporters could stress kidney tissue over time has not been directly studied in people.
The Lab Study That Fuels the Kidney Concern
The most commonly cited piece of evidence linking mannose to kidney harm comes from a study on embryonic kidney tissue. Researchers exposed developing rat kidneys (metanephric kidneys, the precursors that form during fetal development) to mannose and observed structural abnormalities. The study found that mannose reduced intracellular ATP levels, essentially depleting the cells’ energy supply. The authors suggested that mannose causes this energy drain by being consumed in cellular processes, which in turn disrupts the production of certain heavily glycosylated proteins like proteoglycans, leading to abnormal kidney development.7PubMed Central. Mannose-induced dysmorphogenesis of metanephric kidney. Role of proteoglycans and adenosine triphosphate
This result sounds alarming in isolation, but context matters enormously. The study used embryonic tissue, not mature adult kidneys. Developing organs are vastly more sensitive to metabolic disruption than fully formed ones, because they are actively building structures that adult tissue simply maintains. The concentrations of mannose used in the culture medium were also far higher than what oral supplementation produces in human blood. Extrapolating from an in vitro embryonic model to an adult taking a 2 g daily supplement requires leaps that the existing evidence does not support.
That said, the mechanism the study identified, ATP depletion in kidney cells exposed to high mannose concentrations, is not trivial. It points to a theoretical risk if mannose levels in kidney tissue were to become extreme. The question is whether oral supplementation can actually produce those tissue concentrations in a living adult. Nothing in the human trial data suggests it does at standard doses.
Blood Mannose Levels and Kidney Disease
A separate line of research has found that people with chronic kidney disease tend to have higher circulating mannose levels. A study using Mendelian randomization, a method that uses genetic variants to test whether an association between a substance and a disease is likely to be causal, examined mannose in the context of chronic kidney disease pathogenesis.8PubMed Central. Mannose and glycine: Metabolites with potentially causal implications in chronic kidney disease pathogenesis This kind of finding is often misread as proof that mannose damages kidneys. The relationship is more complicated than that.
When kidneys are impaired, they are less efficient at filtering and processing all sorts of metabolites, mannose included. Higher blood mannose in kidney disease patients could simply reflect reduced clearance rather than mannose being the cause of the damage. Similarly, a human metabolic study found that while mannose levels correlated with insulin resistance, administering mannose to people for a week did not worsen insulin signaling or inflammatory markers, suggesting mannose was a marker of the metabolic problem rather than a driver of it.3PubMed. Metabolism The same logic may apply to kidney disease: elevated mannose shows up alongside kidney dysfunction because the kidneys normally keep mannose levels in check, and when they falter, mannose accumulates. Whether that accumulation then worsens the kidney damage is an open question, but the evidence so far leans toward mannose being a bystander, not a perpetrator.
Why Pregnancy Deserves Special Caution
The embryonic kidney study raises a specific flag for pregnant women. If high mannose concentrations can disrupt developing kidney tissue in a laboratory setting, there is at least a theoretical concern about very high maternal mannose levels during fetal kidney formation. No human study has documented this occurring from oral D-mannose supplementation during pregnancy, and the doses used in lab cultures are not comparable to what a supplement delivers to a fetus through the placenta. Still, the absence of safety data in pregnant women is itself a reason for caution. Most clinicians and researchers recommend against using D-mannose supplements during pregnancy simply because the safety profile has not been established for that population, not because harm has been demonstrated.
Children and D-Mannose Tolerance
Pediatric use of D-mannose has been studied in at least one clinical context. A study involving children with complex urological conditions prescribed D-mannose at weight-adjusted doses: roughly 15 mg per kilogram for the youngest patients, scaling up to 500 mg three times daily for adolescents aged 12 to 16. The supplement was well tolerated, with only one child developing slightly loose stools as a side effect.9Archives of Pediatrics. D-Mannose Reduces the Risk of UTI in Complex Paediatric Urology Patients No kidney-related problems were reported. These were children with existing urological issues, meaning their urinary tracts were already under stress, and D-mannose did not appear to add to that burden at the doses used.
That said, the study was small and the duration was limited. Children metabolize substances differently from adults, and their kidneys are still maturing through adolescence. Weight-based dosing, as this study used, is the standard approach for pediatric supplements and medications, and it keeps the per-kilogram exposure lower than what adults typically take.
What About People With Existing Kidney Problems
This is where the evidence gets genuinely thin. The major clinical trials of D-mannose excluded participants with significant kidney disease. That means we have no controlled data on how impaired kidneys handle a daily mannose supplement. In theory, kidneys that are already struggling to filter waste might not process supplemental mannose as efficiently, potentially leading to higher blood levels. Whether those higher levels would cause harm is unknown.
The renal transport system described earlier has limited capacity even in healthy kidneys.5PubMed. Expression and molecular characterization of rat renal D-mannose transport in Xenopus oocytes In someone with reduced kidney function, the number of functional transporters is presumably lower, which could mean less efficient reabsorption and potentially more mannose lingering in the tubular fluid or spilling back into the blood. Whether that matters clinically is speculative. The caution is straightforward: if your kidneys are already impaired, adding any unnecessary metabolic load is worth thinking twice about, even if the substance has not been proven harmful. This is not unique to D-mannose; the same logic applies to many supplements and even some foods.
Gastrointestinal Side Effects Are More Common Than Kidney Ones
When people do report problems with D-mannose, the complaints are almost always gastrointestinal. Bloating, loose stools, and diarrhea are the most frequently mentioned side effects in trial reports and clinical experience. D-mannose is a sugar, and like other poorly absorbed sugars (think of sugar alcohols in sugar-free candy), it can draw water into the intestines and feed gut bacteria, producing gas. At 2 g per day, most people tolerate it fine. At higher doses, or in people with sensitive digestive systems, these effects become more likely.
The pediatric study noted only one case of slightly loose stools across its patient group.9Archives of Pediatrics. D-Mannose Reduces the Risk of UTI in Complex Paediatric Urology Patients Adult trials similarly report minimal adverse events. The practical takeaway is that your gut will usually complain long before your kidneys would, and that gastrointestinal discomfort at higher doses serves as a natural ceiling on how much most people will comfortably take.
D-Mannose and Blood Sugar
Because D-mannose is chemically a sugar, people with diabetes sometimes worry about its effects on blood glucose. The reassuring finding here is that mannose is handled differently from glucose by the body. Only a small fraction of ingested mannose is converted to glucose, and most of it is excreted or used for glycoprotein synthesis. The human study that administered roughly 7 g twice daily found no negative effects on meal-modified glucose tolerance or insulin levels over a week.3PubMed. Metabolism
Animal research has gone further, suggesting D-mannose may actually improve metabolic function. A study in diabetic mice found that D-mannose supplementation in drinking water reduced fasting blood glucose, improved glucose tolerance, and promoted insulin sensitivity. The same study observed improvements in multiple organs affected by diabetes.10PubMed Central. D‐Mannose Alleviates Type 2 Diabetes and Rescues Multi‐Organ Deteriorations by Controlling Release of Pathological Extracellular Vesicles These are mouse results and cannot be directly applied to humans, but they do suggest that D-mannose is unlikely to worsen blood sugar control and might have beneficial metabolic effects that warrant further investigation. For people with diabetes who also get recurrent UTIs, D-mannose at standard doses does not appear to pose a blood sugar risk based on current evidence.
The Supplement Regulation Gap
D-mannose is sold as a dietary supplement, not a pharmaceutical drug. That distinction matters for kidney safety conversations. Supplements are not required to undergo the same pre-market safety testing as medications. Manufacturers do not have to demonstrate that their product is safe for kidneys or any other organ before selling it. They also do not have to prove that the dose on the label matches what is in the bottle, or that the product is free of contaminants.
This means two people buying “2 g D-mannose” from different brands might be getting meaningfully different products. Purity, filler ingredients, and actual mannose content can vary. For someone concerned about kidney safety, this variability is worth considering. A product contaminated with other sugars or metabolites could have different effects than pure D-mannose. Third-party testing certifications from independent labs offer some reassurance, but they are voluntary and not all brands pursue them.
How the Kidney Transporter Limits Exposure
One underappreciated aspect of D-mannose safety is that the kidney’s own transport system creates a natural bottleneck. The dedicated mannose transporter in the kidney tubules has high affinity but limited capacity.4PubMed. A D-mannose transport system in renal brush-border membranes Once the transporter is saturated, additional mannose in the filtrate cannot be reabsorbed and passes into the urine. This means the kidney cells themselves are not exposed to unlimited amounts of mannose even if you take a large oral dose. The transporter acts as a gatekeeper: it pulls back a set amount, and everything else washes through.
Importantly, the mannose transporter operates independently of the glucose transporter. Research found that even at concentrations up to 50 mM, D-mannose did not inhibit sodium-dependent glucose uptake.4PubMed. A D-mannose transport system in renal brush-border membranes This means taking D-mannose supplements should not interfere with how your kidneys handle glucose, which addresses a theoretical concern about metabolic crosstalk in the kidney tubules. The two systems operate on parallel tracks.
What a Meaningful Safety Study Would Look Like
The honest summary of the evidence is that we have reassuring short-term human data, concerning but non-transferable embryonic lab data, and a complete blank where long-term high-dose kidney safety studies should be. A study that would actually answer the title question would need to follow people taking D-mannose at various doses for at least a year, measuring kidney function markers like creatinine clearance and cystatin C at regular intervals. It would need to include some participants with mild to moderate kidney impairment, since those are the people most likely to be affected. And it would need doses that bracket and exceed the typical supplement range, perhaps 2 g, 5 g, and 10 g daily, to find where problems begin if they exist at all.
No such study has been conducted. Until it is, the working answer remains that standard doses of around 2 g per day appear safe for kidneys in healthy adults based on trials lasting up to six months, that higher doses up to about 14 g per day did not cause obvious harm over one week, and that we cannot give a confident answer about long-term use, very high doses, or people with kidney disease. If you fall into one of those uncertain categories, the conversation belongs with your doctor, who can weigh your individual kidney function against the potential benefit of the supplement.